Medivolve Closes Acquisition of Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States
New platform supports Medivolve’s position as a growing health technology and services company
Medivolve Expands Portfolio of Pharmacy Acquisitions with Agreement to Acquire Outstanding Shares of CalVax Licensed Marbella Pharmacy
Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow.
Medivolve Corporate Update Webinar – May 11th 2021
https://www.youtube.com/watch?v=STjOgDQMlLo
Medivolve Announces an Investor Webinar Tuesday, May 11 at 11 am ET
Toronto, Ontario May 6, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to transform human health management, today announces that a webinar will be held on Tuesday, May 11th at 11 am ET. The webinar will feature newly appointed Medivolve CEO, David Preiner…
Medivolve Signs Agreement to Acquire Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States
New platform supports Medivolve’s position as a growing health technology and services company
Medivolve and Marvel Diagnostics Successfully Complete First Stage Clinical Testing of BlowFISH, a Non-Invasive Exhaled Breath Diagnostic Technology For COVID-19, Developed by a UCLA Research Team Led by Dr. Pirouz Kavehpour
Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic technology that has cleared the first milestone in a series of clinical tests and has entered the next phase toward applying for an Emergency Use Authorization from the…